Clinical Trials Logo

Clinical Trial Summary

Anemia is a common problem during pregnancy. Most studies have demonstrated that anemia during pregnancy have adverse effects on their pregnancy outcome, which is important and should pay attention to prevent and solve such problems. The most common cause of anemia is iron deficiency. Several studies reveal that Vitamin C promotes iron absorption. In this study we will compare between Vitamin C with iron supplement and iron supplement alone in prevention of anemia in pregnancy.


Clinical Trial Description

Anemia in pregnancy associated with Diabetes during pregnancy 15.9 % Fetal abnormalities in blood oxygen causing fetal non reassuring 9.4% , Preterm delivery 8.2 %, Amniotic fluid insufficiency 1.95 %, 10.6 % of infants had complications after birth, 9.7 % of infants were hospitalized in intensive care units with birth weight less than 2,500 grams . (Low birth weight) 4.9%, anemia also significantly increased the likelihood of blood transfusion during pregnancy. There is also a study on the risk of developing anemia such as more than 2 pregnancies, Teenage pregnancy, Advanced maternal age more than 35 years old, Mothers with a body mass index below 18 are at increased risk of developing anemia. The most common cause of anemia during pregnancy is iron deficiency. This may be caused by receiving the element. not enough iron or there is a loss of iron from blood loss which is important and should pay attention to prevent and solve such problems. Which Vitamin C promotes iron absorption. Vitamin C combined with iron has been studied. It clearly increases hemoglobin and hematocrit. And is safe for pregnant women and babies. There is also no evidence that vitamin C is a carcinogen, or a cause of birth defects or toxicity. However, there are no studies related to the combination of vitamin C and iron in pregnant women at risk of anemia. To solve the problem and prevent the consequences of the above mentioned anemia. In this study we will compare between Vitamin C with iron supplement and iron supplement alone in prevention of anemia in pregnancy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05975125
Study type Interventional
Source Rajavithi Hospital
Contact Lalitpan Srimaneesiri, M.D.
Phone 0815645290
Email beamsish@gmail.com
Status Recruiting
Phase N/A
Start date June 28, 2023
Completion date June 27, 2024

See also
  Status Clinical Trial Phase
Completed NCT03522428 - Vitamin B12 Pregnancy Supplementation Phase 4
Not yet recruiting NCT06061393 - Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia Phase 4
Active, not recruiting NCT05739097 - Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Recruiting NCT03448432 - Prevalence Study of the Etiology of Pregnancy Anemia N/A
Enrolling by invitation NCT04810546 - Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy N/A
Withdrawn NCT03873571 - Adherence of Iron Succinylate Therapy in Pregnancy
Completed NCT04517734 - Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis
Recruiting NCT06434870 - Effect of Spinal Anesthesia in Elective Cesarean Cases on Frontal QRS Angle in Anemic and Non-Anemic Patients
Completed NCT04812821 - Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital